<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - DIAZEPAM</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>DIAZEPAM</h1>

        <p><a href="../drugClass/PHP34584.html">BENZODIAZEPINES</a></p>

      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#hepaticImpairment" data-toggle="tab">Hepatic impairment</a></li>
          <li><a href="#renalImpairment" data-toggle="tab">Renal impairment</a></li>
          <li><a href="#contraindications" data-toggle="tab">Contra indications</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#directionsForAdministration" data-toggle="tab">Administration</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#importantSafetyInformation" data-toggle="tab">Important safety information</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#unlicensedUse" data-toggle="tab">Unlicensed use</a></li>
          <li><a href="#professionSpecificInformation" data-toggle="tab">Profession specific information</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Muscle spasm of varied aetiology</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                2&#8211;15 mg daily in divided doses, then increased if necessary to 60 mg daily, adjusted according to response, dose only increased in spastic conditions.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Acute muscle spasm</span>,
            </h4>
            <p class="specificity"><span class="route">By intramuscular injection or by slow intravenous injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                10 mg, then 10 mg after 4 hours if required, intravenous injection to be administered into a large vein at a rate of no more than 5 mg/minute.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Tetanus</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion or by nasoduodenal tube</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                100&#8211;300 micrograms/kg every 1&#8211;4 hours.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                3&#8211;10 mg/kg, adjusted according to response, to be given over 24 hours.</li>
              <li class="dose child"><strong>For children </strong><br/>
                100&#8211;300 micrograms/kg every 1&#8211;4 hours.</li>
              <li class="dose child"><strong>For children </strong><br/>
                3&#8211;10 mg/kg, adjusted according to response, to be given over 24 hours.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Muscle spasm in cerebral spasticity or in postoperative skeletal muscle spasm</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose child"><strong>For children 1&#8211;11 months</strong><br/>
                Initially 250 micrograms/kg twice daily.</li>
              <li class="dose child"><strong>For children 1&#8211;4 years</strong><br/>
                Initially 2.5 mg twice daily.</li>
              <li class="dose child"><strong>For children 5&#8211;11 years</strong><br/>
                Initially 5 mg twice daily.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                Initially 10 mg twice daily; maximum 40 mg per day.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Anxiety</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                2 mg 3 times a day, then increased if necessary to 15&#8211;30 mg daily in divided doses, for debilitated patients, use elderly dose.</li>
              <li class="dose adult"><strong>For adults elderly</strong><br/>
                1 mg 3 times a day, then increased if necessary to 7.5&#8211;15 mg daily in divided doses.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Insomnia associated with anxiety</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                5&#8211;15 mg daily, to be taken at bedtime.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Severe acute anxiety</span>,
                <span class="indication">Control of acute panic attacks</span>,
                <span class="indication">Acute alcohol withdrawal</span>,
            </h4>
            <p class="specificity"><span class="route">Initially by intramuscular injection or by slow intravenous injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                10 mg, then (by intramuscular injection or by intravenous injection) 10 mg after at least 4 hours if required, intravenous injection to be administered into a large vein, at a rate of not more than 5 mg/minute.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Acute drug-induced dystonic reactions</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                5&#8211;10 mg, then 5&#8211;10 mg after at least 10 minutes as required, to be administered into a large vein, at a rate of not more than 5 mg/minute.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Acute anxiety and agitation</span>,
            </h4>
            <p class="specificity"><span class="route">By rectum</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                500 micrograms/kg, then 500 micrograms/kg after 12 hours as required.</li>
              <li class="dose adult"><strong>For adults elderly</strong><br/>
                250 micrograms/kg, then 250 micrograms/kg after 12 hours as required.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Premedication</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                5&#8211;10 mg, to be given 1&#8211;2 hours before procedure, for debilitated patients, use elderly dose.</li>
              <li class="dose adult"><strong>For adults elderly</strong><br/>
                2.5&#8211;5 mg, to be given 1&#8211;2 hours before procedure.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                100&#8211;200 micrograms/kg, to be administered into a large vein at a rate of not more than 5 mg/minute, immediately before procedure.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Sedation in dental procedures carried out in hospital</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Up to 20 mg, to be given 1&#8211;2 hours before procedure.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Conscious sedation for procedures, and in conjunction with local anaesthesia</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                5&#8211;10 mg, to be given 1&#8211;2 hours before procedure, for debilitated patients, use elderly dose.</li>
              <li class="dose adult"><strong>For adults elderly</strong><br/>
                2.5&#8211;5 mg, to be given 1&#8211;2 hours before procedure.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Sedative cover for minor surgical and medical procedures</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                10&#8211;20 mg, to be administered into a large vein over 2&#8211;4 minutes, immediately before procedure.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Status epilepticus</span>,
                <span class="indication">Febrile convulsions</span>,
                <span class="indication">Convulsions due to poisoning</span>,
            </h4>
            <p class="specificity"><span class="route">By rectum</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                10 mg, then 10 mg after 10 minutes if required, administered at a rate of 1 mL (5 mg) per minute.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                10&#8211;20 mg, then 10&#8211;20 mg after 10 minutes if required.</li>
              <li class="dose adult"><strong>For adults elderly</strong><br/>
                10 mg, then 10 mg after 10&#8211;15 minutes if required.</li>
              <li class="dose child"><strong>For children 1 month&#8211;11 years</strong><br/>
                300&#8211;400 micrograms/kg (max. per dose 10 mg), then 300&#8211;400 micrograms/kg after 10 minutes (max. per dose 10 mg) if required, to be given over 3&#8211;5 minutes.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                10 mg, then 10 mg after 10 minutes if required, to be given over 3&#8211;5 minutes.</li>
              <li class="dose child"><strong>For children 1 month&#8211;1 year</strong><br/>
                5 mg, then 5 mg after 10 minutes if required.</li>
              <li class="dose child"><strong>For children 2&#8211;11 years</strong><br/>
                5&#8211;10 mg, then 5&#8211;10 mg after 10 minutes if required.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                10&#8211;20 mg, then 10&#8211;20 mg after 10 minutes if required.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Life-threatening acute drug-induced dystonic reactions</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous injection</span></p>
            <ul class="doses">
              <li class="dose child"><strong>For children 1 month&#8211;11 years</strong><br/>
                100 micrograms/kg, repeated if necessary, to be given over 3&#8211;5 minutes.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                5&#8211;10 mg, repeated if necessary, to be given over 3&#8211;5 minutes.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Dyspnoea associated with anxiety in palliative care</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                5&#8211;10 mg daily.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Pain of muscle spasm in palliative care</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                5&#8211;10 mg daily.</li>
            </ul>
          </section>
        </section>
        
        
        
        
        
      </section>



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <p>Women who have seizures in the second half of pregnancy should be assessed for eclampsia before any change is made to antiepileptic treatment. Status epilepticus should be treated according to the standard protocol.</p>
            </section>
            <section class="generalInformation">
                <h3>Epilepsy and Pregnancy Register</h3>
              <p>All pregnant women with epilepsy, whether taking medication or not, should be encouraged to notify the UK Epilepsy and Pregnancy Register (Tel: 0800 389 1248).</p>
            </section>
      </section>

      <section class="tab-pane" id="hepaticImpairment">
        <h2>Advice regarding hepatic impairment</h2>

            <section class="doseAdjustments">
              <p>Start with smaller initial doses or reduce dose.</p>
            </section>
            <section class="generalInformation">
              <p>Can precipitate coma.</p><p>If treatment is necessary, benzodiazepines with shorter half lives are safer, such as temazepam or oxazepam.</p><p>Avoid in severe impairment.</p>
            </section>
      </section>

      <section class="tab-pane" id="renalImpairment">
        <h2>Advice regarding renal impairment</h2>

            <section class="doseAdjustments">
              <p>Start with small doses in severe impairment.</p>
            </section>
        
      </section>

      <section class="tab-pane" id="contraindications">
        <h2>Contra indications</h2>

          <ul>
            <li>Avoid injections containing benzyl alcohol in neonates</li>
            <li><strong>adults:</strong> chronic psychosis in adults</li>
            <li>CNS depression</li>
            <li>compromised airway</li>
            <li>hyperkinesis</li>
            <li><strong>adults:</strong> not for use alone to treat depression (or anxiety associated with depression) in adults</li>
            <li>obsessional states</li>
            <li>phobic states</li>
            <li>respiratory depression</li>
          </ul>
      </section>

      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

          <h3>General side effects</h3>
              <p>
                <strong>commonOrVeryCommon:</strong> Amnesia, ataxia in children, ataxia (especially in the elderly) in adults, confusion in children, confusion (especially in the elderly) in adults, dependence, drowsiness the next day, lightheadedness the next day, muscle weakness, paradoxical increase in aggression,
              </p>
              <p>
                <strong>uncommon:</strong> Changes in libido in adults, dizziness, dysarthria, gastro-intestinal disturbances, gynaecomastia, headache in adults, hypotension in adults, incontinence, salivation changes, slurred speech in adults, tremor, urinary retention in adults, vertigo in adults, visual disturbances,
              </p>
              <p>
                <strong>rare:</strong> Apnoea, blood disorders, changes in libido in children, headache in children, hypotension in children, jaundice, respiratory depression, skin reactions, urinary retention in children, vertigo in children,
              </p>
              <p>
                <strong>notKnown:</strong> Delusions in children, excitement in children, hallucinations in children, hypotonia (when used for muscle spasm), irritability in children, marked respiratory depression, particularly with high dose (facilities for its treatment are essential), psychosis in children, restlessness in children,
              </p>
        
          <h3>Specific side effects</h3>
              <p>
                <strong>notKnown:</strong> pain, thrombophlebitis, venous thrombosis in adults,
              </p>
        
        
      </section>

      <section class="tab-pane" id="directionsForAdministration">
        <h2>Directions for administration</h2>

            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in children</h3>
              <p>For <i>continuous intravenous infusion</i> of diazepam emulsion, dilute to a concentration of max. 400&#8239;micrograms/mL with Glucose 5% or 10%; max. 6 hours between addition and completion of infusion.</p><p>For <i>continuous intravenous infusion</i> of diazepam solution, dilute to a concentration of max. 50&#8239;micrograms/mL with Glucose 5% or Sodium Chloride 0.9%.</p>
            </section>
            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use</h3>
              <p>Diazepam is adsorbed by plastics of infusion bags and giving sets.</p>
            </section>
            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in adults</h3>
              <p>For <i>intravenous infusion</i> (solution) (<i>Diazepam</i>, Wockhardt), give continuously <i>in</i> Glucose 5% or Sodium chloride 0.9%. Dilute to a concentration of not more than 10&#8239;mg in 200&#8239;mL.</p>
            </section>
            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in adults</h3>
              <p>For <i>intravenous infusion</i> (emulsion) (<i>Diazemuls</i>
            <tm tmtype="reg"/>), give continuously <i>in</i> Glucose 5% or 10%. May be diluted to a max. concentration of 200&#8239;mg in 500&#8239;mL; max. 6 hours between addition and completion of administration.</p><p>May be given <i>via</i> drip tubing <i>in</i> Glucose 5% or 10% or Sodium chloride 0.9%.</p>
            </section>
            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use</h3>
              <p>Emulsion formulation preferred for intravenous injection.</p>
            </section>
            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intramuscular</ph> use or <ph outputclass="route">intravenous</ph> use in adults</h3>
              <p>Solution for injection should not be diluted, except for intravenous infusion.</p>
            </section>
            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intramuscular</ph> use in adults</h3>
              <p>Only use intramuscular route when oral and intravenous routes not possible.</p>
            </section>
      </section>

      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

            <section class="generalPatientAdvice">
              <p>Patients given sedatives and analgesics during minor outpatient procedures should be very carefully warned about the risks of undertaking skilled tasks (e.g. driving) afterwards. For intravenous benzodiazepines the risk extends to <b>at least 24 hours</b> after administration. Responsible persons should be available to take patients home afterwards. The dangers of taking <b>alcohol</b> should be emphasised.</p>
            </section>
            <section class="patientResources">
              <h3 class="specificity">In children</h3>
                <p class="title">Medicines for Children leaflet: Diazepam (rectal) for stopping seizures</p>
              <p>
            <xref format="html" href="http://www.medicinesforchildren.org.uk/diazepam-rectal-stopping-seizures-0">www.medicinesforchildren.org.uk/diazepam-rectal-stopping-seizures-0</xref>
            </p>
            </section>
            <section class="patientResources">
              <h3 class="specificity">In children</h3>
                <p class="title">Medicines for Children leaflet: Diazepam for muscle spasm</p>
              <p>
            <xref format="html" href="http://www.medicinesforchildren.org.uk/diazepam-for-muscle-spasm">www.medicinesforchildren.org.uk/diazepam-for-muscle-spasm</xref>
            </p>
            </section>
      </section>


      <section class="tab-pane" id="importantSafetyInformation">
        <h2>Important safety information</h2>

            <section class="importantSafetyInformation">
                <h3>Anaesthesia</h3>
              <p>Benzodiazepines should only be administered for anaesthesia by, or under the direct supervision of, personnel experienced in their use, with adequate training in anaesthesia and airway management.</p>
            </section>
      </section>

      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
            Muscle weakness
          </li>
          <li>
            organic brain changes
          </li>
          <li>
            parenteral administration (close observation required until full recovery from sedation)
          </li>
          <li>
            personality disorder (within the fearful group&#8212;dependent, avoidant, obsessive-compulsive) may increase risk of dependence
          </li>
        </ul>
        <ul>
          <li>
              <strong>With intravenous use:</strong>
            high risk of venous thrombophlebitis with intravenous use (reduced by using an emulsion formulation)
          </li>
        </ul>
        <ul>
          <li>
              <strong>With <ph outputclass="route">intravenous</ph> use:</strong>
            <p>When given intravenously facilities for reversing respiratory depression with mechanical ventilation must be immediately available.</p>
          </li>
          <li>
            <p>A paradoxical increase in hostility and aggression may be reported by patients taking benzodiazepines. The effects range from talkativeness and excitement to aggressive and antisocial acts. Adjustment of the dose (up or down) sometimes attenuates the impulses. Increased anxiety and perceptual disorders are other paradoxical effects.</p>
          </li>
        </ul>
      </section>



      <section class="tab-pane" id="unlicensedUse">
        <h2>Unlicensed use</h2>

            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">rectal</ph> use in children</h3>
              <p>
            <i>Diazepam Desitin</i>
            <sup>
            <tm tmtype="reg"/>
            </sup>, <i>Diazepam Rectubes</i>
            <sup>
            <tm tmtype="reg"/>
            </sup>, and <i>Stesolid Rectal Tubes</i>
            <sup>
            <tm tmtype="reg"/>
            </sup> not licensed for use in children under 1 year.</p>
            </section>
      </section>







      <section class="tab-pane" id="professionSpecificInformation">
        <h2>Profession specific information</h2>

          <h3>Dental practitioners</h3>
        
            <section class="dentalPractitionersFormulary">
              <p>Diazepam Tablets may be prescribed.</p><p>Diazepam Oral Solution 2&#8239;mg/5&#8239;mL may be prescribed.</p>
            </section>
      </section>



      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of DIAZEPAM</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        
          <strong>Forms available from special-order manufacturers include: </strong>
            suppository,
            oral suspension,
            oral solution,

            <div id="PHP75159"><a href="../medicinalForm/PHP75159.html" data-target="#PHP75159" data-action="load">Tablet</a></div>
            <div id="PHP75199"><a href="../medicinalForm/PHP75199.html" data-target="#PHP75199" data-action="load">Oral solution</a></div>
            <div id="PHP75173"><a href="../medicinalForm/PHP75173.html" data-target="#PHP75173" data-action="load">Solution for injection</a></div>
            <div id="PHP75185"><a href="../medicinalForm/PHP75185.html" data-target="#PHP75185" data-action="load">Emulsion for injection</a></div>
            <div id="PHP75166"><a href="../medicinalForm/PHP75166.html" data-target="#PHP75166" data-action="load">Enema</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
